陳 建信

Medicine & Life Sciences

1. Adenocarcinoma 100%
2. Taiwan 79%
3. Chemoradiotherapy 65%
4. Rectal Neoplasms 65%
5. Neoplasm Metastasis 61%
6. Survival Rate 51%
7. Case-Control Studies 49%
8. Neoplasms 49%
9. Colorectal Neoplasms 49%
10. Simple Mastectomy 44%
11. Waist-Height Ratio 43%
12. Cytoreduction Surgical Procedures 40%
13. Leukocyte Elastase 39%
14. Induced Hyperthermia 37%
15. Heme Oxygenase-1 36%
16. NADPH Oxidases 35%
17. Angiotensin Receptor Antagonists 34%
18. Colectomy 34%
19. Adenocarcinoma of Lung 33%
20. Robotics 32%
21. Phosphatidylinositol 3-Kinases 30%
22. Angiotensin-Converting Enzyme Inhibitors 30%
23. Epidermal Growth Factor 30%
24. Drug Therapy 28%
25. Laparoscopy 28%
26. Colonic Neoplasms 28%
27. Reproducibility of Results 27%
28. Recurrence 27%
29. Fatigue 26%
30. Confidence Intervals 25%
31. Cognition 24%
32. Radiotherapy 23%
33. Lung 23%
34. Databases 23%
35. Survival 22%
36. Regression Analysis 20%
37. Liver 20%
38. Breast Neoplasms 19%
39. Blood Pressure 19%
40. HT29 Cells 16%
41. Odds Ratio 14%
42. Child 13%
43. sivelestat 13%
44. Kaplan-Meier Estimate 12%
45. Therapeutics 12%
46. Lung Neoplasms 12%
47. Population 12%
48. Lymph Nodes 10%
49. Mortality 10%
50. Disease-Free Survival 9%